Fingerprint

Dive into the research topics of 'Phase I trial of concurrent stereotactic body radiotherapy and nelfinavir for locally advanced borderline or unresectable pancreatic adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences